Sep 08, 2022 / 12:50PM GMT
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director
Everyone, mainly the people on the webcast, but okay. It's a great pleasure to have senior management from Zai Lab here. I've been following Zai Lab since they were a private company back in 2017. In fact, I've been to China a few times to see their operations. So I want to welcome Billy Cho, CFO; Josh Smiley, COO, who just recently joined the company officially, I think August 1.
Joshua L. Smiley - Zai Lab Limited - COO
That's right. Yes.
Questions and Answers:
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - DirectorSo welcome both of you. I guess at a high level, I think we can just start by a broad strategy question. What is Zai's mission? How are you different from some of your key competitors in the China biotech space? And what's the core investment case for Zai Lab?
Joshua L. Smiley - Zai Lab Limited - COO
Sure. No, thanks, Yigal, and thanks for having us. I think it's pretty